Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap985.60M
Enterprise Value1.54B
TNDM
(NASDAQ)Tandem Diabetes Care, Inc.
$14.41-- (--)
Loading... - Market loading
Tandem Diabetes Care (TNDM) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)0.96
Forward Price/Sales0.92
Price/Book (mrq)7.44
Price/Tangible Book (mrq)7.44
Price/OCF (ttm)50.26
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue1.50
EV/Earnings-16.30
EV/EBITDA-22.49
EV/EBIT-8.24
EV/FCF-423.24
Stock Price
Current price, 52-week range, and moving averages
Current Price$14.41
1-Day Change0.49%
52-Week High$29.65
52-Week Low$9.98
52-Week Change-28.73%
YTD Change-33.13%
1-Year Change-28.59%
50-Day MA$17.43
200-Day MA$18.55
Avg Volume (30 day)2.84M
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding68.40M
Book Value per Share$1.94
Net Cash per Share$-8.12
FCF per Share$-0.05
Analyst Price Targets & Consensus
Wall Street analyst ratings and 12-month price targets (90 days)
Price Target$32.38
Target Upside/Downside124.71%
Analyst ConsensusBuy
Analyst Count15
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin54.93%
EBITDA Margin (ttm)-6.67%
EBIT Margin (ttm)-18.21%
Operating Margin (ttm)-7.88%
Pretax Margin (ttm)-9.54%
Profit Margin (ttm)-9.20%
FCF Margin (ttm)-0.35%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)-71.41%
Return on Assets (ttm)-8.20%
Return on Invested Capital (ttm)-21.49%
Return on Capital Employed (ttm)-20.67%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue1.03B
Gross Profit564.39M
Operating Income-81.01M
Pretax Income-98.06M
Net Income-94.55M
EBITDA-68.52M
EBIT-187.11M
Diluted EPS$-1.39
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow19.61M
Capital Expenditures23.25M
Free Cash Flow-3.64M
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth-6.78%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)1.15B
Cash & Securities (mrq)179.32M
Net Cash (mrq)-555.41M
Net Cash per Share$-8.12
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)734.74M
Working Capital (mrq)639.14M
Total Equity (mrq)132.40M
Book Value per Share$1.94
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)3.58
Quick Ratio (mrq)3.07
Debt/Equity (mrq)5.55
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$0.00
Dividend Yield0.00%
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield-9.59%
FCF Yield-0.37%
Buyback Yield-0.21%
Total Shareholder Yield-0.21%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score-0.92
Piotroski F-Score3/9
Frequently Asked Questions About Tandem Diabetes Care Statistics
What are the key financial metrics for TNDM?
Tandem Diabetes Care, Inc. (TNDM) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is TNDM's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Tandem Diabetes Care is overvalued or undervalued.
How do I read TNDM's profitability ratios?
Tandem Diabetes Care's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do TNDM's debt ratios indicate?
The financial health section shows Tandem Diabetes Care's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is TNDM's dividend analysis?
The dividend section covers Tandem Diabetes Care's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.